Advances in biotechnology have enabled the identification of several novel biomarkers, which are presently being used for a variety of purposes, including diagnosis, drug development, clinical research and to facilitate therapy-related decisions
Roots Analysis is pleased to announce the publication of its recent study, titled, “Cancer Biomarkers Market: Focus on TMB, MSI / MMR and TILs Testing, 2019–2030.”
The report features an extensive study of the current landscape and future outlook of the immuno-oncology biomarkers testing market (focusing particularly on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+)). It provides an in-depth analysis, highlighting the capabilities of the various companies engaged in this domain. Amongst various elements, the report includes:
- A detailed analysis of ongoing, biomarker-based clinical trials initiated by big pharmaceutical companies.
- An analysis of the landscape of companies offering testing services for cancer biomarkers, namely TMB, MSI / MMR and TILs (including CD3+, CD4+, CD8+ and FOXP3+).
- An insightful 2X2 representation of the results of a detailed competitiveness analysis of various tests (segregated across different biomarker groups).
- Elaborate profiles of leading analytical testing service providers focused on immuno-oncology biomarkers (shortlisted based on strength of service portfolio).
- A detailed publication analysis of over 180 research articles that have been published since 2016, highlighting the key focus areas of ongoing research activity related to immuno-oncology biomarkers, namely TMB, MSI / MMR and TILs.
- A comprehensive clinical trial analysis of completed, ongoing and planned studies, focused on the assessment of cancer biomarkers, namely TMB, MSI / MMR and TILs.
- A discussion on the upcoming opportunities that are likely to impact the evolution of this market over the coming years.
- A discussion on various steps involved in development operations of companion diagnostics
- A comparative analysis of the needs of different stakeholders involved in the development of companion diagnostic products.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Request for Customization:
https://www.rootsanalysis.com/reports/253/request-customization.html
Type of test
- Laboratory Developed Tests (LDTs)
- Companion Diagnostic Tests (CDx)
Type of disease indication
- Breast cancer
- Blood cancer
- Colon / Colorectal cancer
- Lung Cancer
- Melanoma
- Prostate Cancer
Type of cancer biomarker
- TMB
- MSI / MMR
- TILs
Type of analytical technique
- Next Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Immunohistochemistry (IHC)
- Others
Key geographical regions
- North America
- Europe
- Japan
- China
- Australia
Key companies covered in the report
- Foundation Medicine
- NeoGenomics Laboratories
- Novogene
- Q2 Solutions
- Personal Genome Diagnostics
- Dr Lal PathLabs
- Shenzhen Yuce Biotechnology
Enquiry before Purchasing:
https://www.rootsanalysis.com/reports/253/request-sample.html
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com
Please Visit Our Upcoming Reports
Gonorrhea: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031
Lactose Intolerance: Pipeline Review, Developer Landscape and Competitive Insights, 2021-2031
Cold Chain Logistics Market, Industry Trends and Global Forecasts, 2021-2030
Article source: https://article-realm.com/article/Finance/10655-Cancer-Biomarkers-Market-2020-Research-In-Depth-Analysis-Key-Players-Forecasts-to-2030.html
URL
https://www.rootsanalysis.com/reports/view_document/cancer-biomarkers-market-focus-on-tmb-msi--mmr-and-tils-testing-2019--2030/253.htmlCancer Biomarkers Market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis
Reviews
Comments
Most Recent Articles
- Sep 13, 2024 Why SIP in ELSS is a Win-Win for Tax Saving and Wealth Creation by sandeepkumar
- Sep 12, 2024 How Does the Portfolio Overlap Tool Work in Top Mutual Fund Software in India? by Wealth Elite
- Sep 5, 2024 Wealth management versus financial planning by Anna Paquin
- Sep 2, 2024 How Does the Compare Funds Feature in Mutual Fund Software Work? by Wealth Elite
- Aug 29, 2024 How Mutual Fund Software for IFA Helps in Selecting the Right Mutual Fund for Investors? by Wealth Elite
Most Viewed Articles
- 11085 hits How to Start an Invention Idea by Edwin Poul
- 9064 hits How to Download and Install Facebook Messenger on Firestick by Hope Mikaelson
- 2615 hits Brief discussion about Water by kavin prasath
- 2115 hits Importance of Proofreading While You Write an Assignment by clara
- 1891 hits Sleeping Pillow Market by Trisha Kumari
Popular Articles
In today’s competitive world, one must be knowledgeable about the latest online business that works effectively through seo services....
77367 Views
Are you caught in between seo companies introduced by a friend, researched by you, or advertised by a particular site? If that is the...
32686 Views
Walmart is being sued by a customer alleging racial discrimination. The customer who has filed a lawsuit against the retailer claims that it...
13709 Views
If you have an idea for a new product, you can start by performing a patent search. This will help you decide whether your idea could become the...
11085 Views
Statistics
Members | |
---|---|
Members: | 15316 |
Publishing | |
---|---|
Articles: | 63,054 |
Categories: | 202 |
Online | |
---|---|
Active Users: | 187 |
Members: | 0 |
Guests: | 187 |
Bots: | 5400 |
Visits last 24h (live): | 1827 |
Visits last 24h (bots): | 26422 |